PENGHAMBATAN AKTIVITAS XANTHINE OXIDASE OLEH EKSTRAK ETANOL SARANG SEMUT (Myrmecodia tuberosa (non Jack) Bl.) SECARA IN VITRO

Authors

  • Ernawati Ernawati Farmasi UAD
  • Hari Susanti Farmasi UAD

DOI:

https://doi.org/10.12928/pharmaciana.v4i1.393

Keywords:

Uric acid, Hyperuricemia, Xanthine Oxidase, Myrmecodia tuberosa (non Jack) Bl

Abstract

Uric acid is the end product of purine metabolism that can settle in the joints and form small
crystals, causing inflammation known as gout. Gout is a disease caused by high levels of uric acid in
the blood (hyperuricemia). One of the drugs used to treat gout was allopurinol to inhibite the activity
of xanthine oxidase mechanism. Myrmecodia tuberosa (non Jack) Bl. known to contain flavonoids and
empirically proven to treat rheumatic complaints and gout. Therefore, research needs to examine
whether the ethanol extract of the sarang semut to inhibite xanthine oxidase activity. Allopurinol is
used as a comparison. The active substances of the Myrmecodia tuberosa (non Jack) Bl. was extracted
with ethanol using maceration method after soaked with petroleum ether. The xanthine oxidase
inhibitor activity of the Myrmecodia tuberosa (non Jack) Bl production ethanol extract was
spectrophotometrically determined by monitoring the reducing of uric acid at a wavelength
(λ) 295 nm with xanthine as substrate. Rate values obtained subsequently used to calculate the value
of the activity. Then determined the concentration of the ethanol extract can inhibit the activity of
of xanthine oxidase by 50% (IC50). The results of the research showed that the ethanol extracts of
sarang semut inhibited xanthine oxidase activity with IC50 112.40 µg/ml, while allopurinol was
3.16 µg/ml.

Downloads

Published

2014-05-01

Issue

Vol. 4 No. 1 (2014): Pharmaciana

Section

Analytical Pharmacy and Medicinal Chemistry

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.